Randomized Controlled Crossover Comparison of Icon Underwear to Disposable Pads

NCT ID: NCT03263676

Last Updated: 2017-08-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-07-01

Study Completion Date

2017-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a randomized cross over trial to compare quality of life and product performance between Icon reusable underwear versus standard disposable pad in patients with mild to moderate urinary incontinence.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Urinary incontinence is estimated to affect approximately 1/5 of all women in the United States. Multiple studies have compared effectiveness, cost-effectiveness and comfort of a variety absorbent products but most of the current data compares daily disposable insert pads. Icon reusable underwear is a new product on the market for light incontinence (25-30mL daily). The primary objective of this randomized cross over trial is to compare quality of life and patient comfort and to determine patient preference using Icon reusable underwear versus standard incontinence pad in the management of urinary incontinence. The secondary objective is to compare the cost-effectiveness of ICON underwear to disposable pads. Women with small to moderate urinary incontinence to use either ICON underwear or pads for two days and then crossed over to use other product for two days. The primary outcome measures were Incontinence Quality of Life Instrument 3 (I-QOL) and Product Performance Questionnaire 4 (PPQ) after use of each product. A sample size of 70 was calculated to detect a difference of 10.0 in the I-QOL to achieve a power of 80% with a significance level of 0.05 and to account for a 20% attrition.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Reusable Underwear, Urinary Incontinence, Dispoable Pad

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Icon reusable underwear

Group Type EXPERIMENTAL

Disposable pad

Intervention Type DEVICE

Standard market disposable pad

Disposable pad

Group Type PLACEBO_COMPARATOR

Icon resuable underwear

Intervention Type DEVICE

Reusable incontinence underwear

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Icon resuable underwear

Reusable incontinence underwear

Intervention Type DEVICE

Disposable pad

Standard market disposable pad

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female patients who are at least 18yo
* Mild to moderate urinary incontinence, defined as a response "small" or "moderate" amount to the ICIQ-SF question - "How much do you leak?"

Exclusion Criteria

* Active urinary tract infection
* Fecal incontinence, defined as a response "large" amount to the ICIQ-SF question - "How much do you leak?"
Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medstar Health Research Institute

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lee Richter

Role: PRINCIPAL_INVESTIGATOR

Medstar Health Research Institute

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2016-042

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

A Device Study in Healthy Participants
NCT04848402 COMPLETED PHASE1
Tampon Design Validation Study
NCT05553600 COMPLETED NA
PureWick™ Adolescent Study
NCT06631313 COMPLETED NA
Wetness Sensing System
NCT05454813 COMPLETED NA
The Bar Coded Sponge Study
NCT00282750 COMPLETED NA